Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segura, J.
Right arrow Articles by Ruilope, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segura, J.
Right arrow Articles by Ruilope, L. M.
J Am Soc Nephrol 15:1616-1622, 2004
© 2004 American Society of Nephrology


CLINICAL SCIENCE

Development Of Chronic Kidney Disease and Cardiovascular Prognosis in Essential Hypertensive Patients

Julián Segura, Carlos Campo, Paloma Gil, Cecilia Roldán, Luis Vigil, José L. Rodicio and Luis M. Ruilope

Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.

Correspondence to. Dr. Julián Segura, Hypertension Unit. Hospital 12 de Octubre., Av. Córdoba s/n, 28041 Madrid, Spain. Phone: 34-91-3908198; Fax: 34-91-3908035; E-mail: jsegurad{at}senefro.org

ABSTRACT. The existence of a significant percentage of treated hypertensive patients presenting a diminished renal function has been recently described. Mild renal function abnormalities are recognized as powerful predictors of cardiovascular morbidity and mortality. However, longitudinal data demonstrating this association are lacking. The objectives of this study have been analysis of the evolution of GFR, assessed as creatinine clearance (CrCl), during long-term follow-up of hypertensive patients and evaluation of the impact of the development of chronic kidney disease (CKD) on cardiovascular prognosis. A historical cohort of 281 patients attending our Hypertension Unit was selected according to the following criteria: essential hypertension, more than 5 yr of follow-up, and normal GFR at baseline (CrCl > 90 ml/min per 1.73 m2). Patients had an average follow-up of 13.2 ± 4.8 yr. Forty-one patients (14.6%) developed CKD (CrCl < 60 ml/min per 1.73 m2) attributed to hypertensive nephrosclerosis. Initial serum creatinine, age, systolic BP at baseline, and average total cholesterol during follow-up were independent predictors of CKD development. Forty-nine (17.4%) of 281 patients presented a cardiovascular event during follow-up: 17 patients (40.6%) who developed CKD and 32 patients (13.3%) with preserved renal function (log rank test P < 0.001). After adjustment in a Cox multivariate analysis, age, development of CKD during follow-up, and male gender were independent predictors of the appearance of cardiovascular events. In essential hypertensive patients with normal renal function at baseline, the development of CKD during the follow-up is strongly and independently related with poor cardiovascular prognosis.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. Thilly, S. Boini, M. Kessler, S. Briancon, and L. Frimat
Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale)
Nephrol. Dial. Transplant., November 11, 2008; (2008) gfn566v1.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. E. Rifkin, M. G. Shlipak, R. Katz, L. F. Fried, D. Siscovick, M. Chonchol, A. B. Newman, and M. J. Sarnak
Rapid Kidney Function Decline and Mortality Risk in Older Adults
Arch Intern Med, November 10, 2008; 168(20): 2212 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. F. Elsayed, H. Tighiouart, J. Griffith, T. Kurth, A. S. Levey, D. Salem, M. J. Sarnak, and D. E. Weiner
Cardiovascular Disease and Subsequent Kidney Disease
Arch Intern Med, June 11, 2007; 167(11): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. M. Ruilope and J. Segura
Blood pressure lowering or selection of antihypertensive agent: which is more important?
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 843 - 845.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Segura, J. A. Garcia-Donaire, M. Praga, and L. M. Ruilope
Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S136 - S140.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
B. J Epstein and J. G Gums
Angiotensin Receptor Blockers versus ACE Inhibitors: Prevention of Death and Myocardial Infarction in High-Risk Populations
Ann. Pharmacother., March 1, 2005; 39(3): 470 - 480.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP